Muralidhar K Acharya, MD

Hudson Office

Medical School

Kasturba Medical College
Manipal, India - 1971

Residency

Internal Medicine
Detroit General Hospital,
Detroit, MI – 1974-1976

Fellowship

Nephrology
Wayne State University Affiliated Hospitals
Detroit, MI - 1978

Board Certification

American Board of Internal Medicine - 1976
American Board of Internal Medicine/Nephrology - 1978
Detroit, MI - 1978

Founded RHC

1978, Managing Partner 1978 – Present.

MBA

University of South Florida School of Business Administration 1992

Publications

  • Coyne D, Acharya MK, Qiu P, Abboud H, Batlle D, et al. Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD American Journal of Kidney Diseases, 47, 2 (Feb), 2006:263-276
  • Acharya MK, Healy G., Ross J. Dialysis Vascular Access Centers Endovascular Today 61-62 July 2004
  • Acharya MK Microalbuminuria: Kidneys' Window to the Heart. AAPI July 2003
  • Tran H.B., Acharya MK, McKay D.B., Sayegh M.H., Carpenter C.B., Auchincloss H, et al. Avoidance of Cyclosporine in Renal Transplantation: Effects of Daclizumab, Mycophenolate Mofetil, and Steroids. Journal of American Society of Nephrology 11: 1903-1909, 2000.
  • Acharya MK, Masco HL, Rifkin SI, Richman, AV. Minimal Change Disease and Nephrotic Syndrome Associated with Lithium Therapy Annals of Internal Medicine 92(1): 70-72, 1980.